Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Pyruvate Kinase Deficiency (PKDef) in Basenji dogs is a hereditary genetic disorder affecting red blood cell metabolism. This DNA test helps identify carriers and affected dogs, enabling responsible breeding decisions to reduce the prevalence of PKDef. Early detection through genetic screening is crucial for managing the health of Basenjis and preventing anemia-related complications. By using the PKDef DNA test, breeders and owners can ensure healthier blood profiles and improve the overall well-being of their dogs. Regular testing supports the Basenji community in maintaining strong, vibrant bloodlines. Stay proactive with PKDef DNA testing to safeguard your Basenji’s health today.
Pyruvate Kinase Deficiency (PKDef) in Basenjis is a hereditary genetic disorder affecting red blood cells. It results from a mutation in the pyruvate kinase enzyme, leading to anemia and related health issues. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing helps manage the condition and reduce its spread in the breed. Responsible breeding practices are essential to maintain the health of Basenjis.
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Pyruvate Kinase Deficiency (PKDef) is a genetic disorder that affects the red blood cells in dogs, particularly impacting their ability to produce energy. This condition is caused by mutations in the PKLR gene, which encodes for the enzyme pyruvate kinase. This enzyme plays a crucial role in the glycolytic pathway, a metabolic process that converts glucose into energy. In dogs affected by PKDef, the deficiency of this enzyme leads to hemolytic anemia, where red blood cells are destroyed faster than they can be produced.
Dogs with Pyruvate Kinase Deficiency often exhibit various clinical signs that may vary in severity. Common symptoms include lethargy, weakness, pale gums, and an increased heart rate. These signs are often more pronounced during periods of stress or illness, where the body requires more red blood cells to function effectively. In some cases, affected dogs may also experience jaundice, an indication of increased bilirubin levels due to red blood cell breakdown.
The diagnosis of Pyruvate Kinase Deficiency typically involves a combination of clinical evaluation and laboratory testing. A veterinarian may suspect PKDef based on the clinical signs and a complete blood count (CBC) that indicates anemia. Further testing, including a DNA test, can confirm the presence of mutations in the PKLR gene, providing a definitive diagnosis.
While there is currently no cure for Pyruvate Kinase Deficiency, management of the condition focuses on alleviating symptoms and improving the quality of life for affected dogs. Treatment may include blood transfusions during severe anemia episodes, as well as supportive care to manage symptoms. Regular veterinary check-ups are crucial to monitor the dog's health and adjust treatment as needed.
Genetic testing for Pyruvate Kinase Deficiency is invaluable for dog owners, breeders, and veterinarians. By identifying carriers and affected individuals, breeders can make informed decisions to reduce the incidence of this condition in future generations. Additionally, early identification of affected dogs can lead to timely management and better outcomes for those diagnosed with PKDef.
Pyruvate Kinase Deficiency is a significant hereditary condition in dogs that can lead to serious health issues if not managed properly. Understanding the genetic basis, clinical signs, and management options available for PKDef is essential for dog owners and breeders alike. Through awareness and genetic testing, the impact of this condition can be minimized, ensuring healthier dogs in the future.
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
This DNA test detects the mutation associated with Pyruvate Kinase Deficiency In Basenji (PKDef-Ba) in order to identify clear, carrier, or at-risk animals.
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
This test analyses the mutation PKLR c.433del.
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
Whitney K M, Goodman S A, Bailey E M, Lothrop C D Jr. The molecular basis of canine pyruvate kinase deficiency. Exp Hematol. 1994 Aug;22(9):866-74.
Jo privacy, jo kar
Wy brûke essensjele cookies om de webside út te fieren. Opsjonele cookies (lykas oanbieders fan ynbêde ynhâld) binne standert útskeakele en binne allinich ynskeakele as jo it iens binne. Jo kinne jo kar op elk momint feroarje mei de knop "Koekjes".
Fereaske foar kearnfunksjes en feiligens. Altyd ynskeakele.
Ferbetteret funksjes lykas foarkarbesparring of net-reklame-ynbêden.
Helpt ús sitegebrûk te begripen. Standert útskeakele.
Advertearje / folgjen oer siden (guon fideo / kaarten ynbêde). Standert útskeakele.